Delivery Order SPE2DB24D3015-SPE2DB25FFZEH

Award Date 5/1/25
Potential Completion Date 5/22/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance through February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a prescription medication, with a ceiling value of $15,151.52 and a period of performance ending on May 9, 2025. The contract is not set aside and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,575.75, is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance that runs through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication, to the DLA. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 17, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $7,575.75 and a period of performance through April 7, 2025. It is structured as a firm fixed-price delivery order contract, without any set-aside...
This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a firm fixed price of $7,322.67 and a completion date of September 17, 2024. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $43,936.02, is for the delivery of IMBRUVICA 420 MG TABLET 28S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.50 and an ultimate completion date of April 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZEH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $33,865.10 and a completion date of May 22, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:16 AM